[Elsevier]
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and EuropeLancet Psychiatry
. 2022 Jan;9(1):46-58.
doi: 10.1016/S2215-0366(21)00386-2. Epub 2021 Nov 30.